Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT Capsules with Lactobacillus for Recurrent C. difficile
NCT03804736Unknown
- Sponsor
- Universidad Autónoma de Nuevo León
- Start
- Nov 2016
- Primary completion
- Jun 2018
01
Overview
Randomised, open-label trial in Clostridium difficile infection (CDI) (2 arms), sponsored by Universidad Autónoma de Nuevo León. Primary endpoint: Decrease in the number of evacuations at 2 days. Status: unknown.
02
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT03804736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03804736.